Pfizer Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PFIZER.NS | AZN | SANOFI.NS | MRK | GLAXO.BO | SNY | |
|---|---|---|---|---|---|---|
| Market cap | 176.44B | 293.14B | 77.75B | 370.96B | 423.63B | 113.74B |
| P/E (TTM) | 23.2 | 26.7 | 21.3 | 151.9 | 44.4 | 23.6 |
| Forward P/E | 18.8 | 16.7 | 19.0 | 16.7 | 36.9 | 8.9 |
| Price/book | 4.0 | 5.7 | 9.4 | 8.9 | 24.8 | 1.4 |
| Dividend yield | 1.96% | 1.69% | 3.56% | 2.26% | 1.75% | 5.10% |
| 1-year change | −24.33% | +12.81% | −27.30% | +75.29% | +6.17% | −4.08% |
| Today | +0.58% | +2.79% | −2.17% | +3.93% | −1.26% | +4.72% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All PFIZER.NS news ›Pfizer's Eliquis Price Gains Cover COVID Drop: Rapid Earnings Reaction
Pfizer's revenue didn't grow, but the mix underneath it changed a lot. Pfizer (PFE -1.14%) reported flat third-quarter revenue of $16.6 billion and raised its full-year outlook. Shares slipped about 0.2% in premarket trading. Eliquis and…
Pfizer Beats Expectations in Q3 and Raises Its Guidance. Is the Stock Due for a Big Rally?
The healthcare stock may finally have the catalyst that it needs to take off before the end of the year. On Tuesday, healthcare giant Pfizer (PFE -0.99%) reported its third-quarter results, which came in far better than expected.…
Moderna Climbs 5% Ahead of Earnings, Pfizer Eases Despite Raised Outlook, Merck Slides 2% Amid New Phase 3 Trial
Moderna surges on pre-earnings momentum, Pfizer dips after beating estimates and raising guidance, and Merck drops despite launching a new trial. When stock prices and headlines point in opposite directions across the sector, something…
Pfizer Hikes Guidance On Solid Third Quarter, Names Company Vet As New CFO
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…
Pfizer Is Pitched for Its Dividend. The November 3 Report Has to Show Cash Flow Covers It
Pfizer (PFE) is back on income investors’ shopping lists, and its 5.6% dividend yield is the reason. A widely syndicated income piece this week split $250,000 evenly across Pfizer, Merck, UnitedHealth and AbbVie. Pfizer’s $62,500 share…
Pfizer, fresh to China’s obesity market, looks to Viagra model to compete
Pfizer is getting its first taste of the obesity business with partner Sciwind Biosciences as the weight loss drug Ecnoglutide breaks into the Chinese market. But the idea of a consumer-driven market is not new territory for the storied…
Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market
CNBC Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market
Pfizer Raises 2026 Outlook After Strong Third Quarter
Pfizer raised its full-year 2026 financial forecasts on Tuesday, November 3, after reporting third-quarter earnings above Wall Street expectations. The pharmaceutical company credited stronger sales of newer products and ongoing cost…
More from 1 other outlet
Pfizer lifts full-year guidance on robust third quarter.
Pfizer lifted its full-year guidance on Tuesday, after healthy demand for its blood thinners and cancer drugs helped offset falling sales of Covid-19 medicines. Adjusted profits were $0.87 per share, unchanged year-on-year but comfortably…
Pfizer flat in Q3 despite 32% growth for new and acquired products
While Pfizer’s revenue did not rise in the third quarter, the New York pharma pointed to rising sales of launched and acquired products as evidence of a sustained effort to drive longer-term growth. The company reported revenue of $16.6…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- 247wallst.com24
- theglobeandmail.com20
- fool.com19
- seekingalpha.com13
- marketscreener.com10
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.